Sclerotherapy (hypertonic glucose plus polidocanol) vs sclerotherapy (hypertonic glucose)
Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins
Sclerotherapy (hypertonic glucose plus polidocanol) showed no clear difference in adverse events ‐ hyperpigmentation ( compared with sclerotherapy (hypertonic glucose) (moderate certainty).
1 finding from 1 review
- RR 0.79 [0.62, 1.01]2 studies · 191 participantsModerate